• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome.

作者信息

Westberg G, Wängberg B, Ahlman H, Bergh C H, Beckman-Suurküla M, Caidahl K

机构信息

Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.

出版信息

Br J Surg. 2001 Jun;88(6):865-72. doi: 10.1046/j.0007-1323.2001.01798.x.

DOI:10.1046/j.0007-1323.2001.01798.x
PMID:11412260
Abstract

BACKGROUND

The association between malignant midgut carcinoid tumours and right-sided cardiac lesions is well known, but the pathogenetic link between tumour secretion and valvular disease is still obscure. The purpose of this investigation was to describe the morphological and functional changes of valvular heart disease in a large patient series and to correlate these findings with hormonal secretion and prognosis.

METHODS

Of 64 consecutive patients with the midgut carcinoid syndrome followed between 1985 and 1998, valvular heart disease was evaluated in 52 patients by two-dimensional echocardiography, Doppler estimation of valvular regurgitation and flow profiles. A majority was also evaluated with exercise electrocardiography and spirometry.

RESULTS

Structural and functional abnormalities of the tricuspid valve were found in 65 per cent of patients, while only 19 per cent had pulmonary valve regurgitation. Long-term survival was related to excessive urinary excretion of 5-hydroxyindole acetic acid of over 500 micromol in 24 h, but the main predictor of prognosis was the presence of severe structural and functional abnormalities of the tricuspid valve. Although advanced tricuspid abnormalities were prevalent in this series, only one patient died from right ventricular heart failure.

CONCLUSION

Tricuspid valvular disease is a common manifestation of the midgut carcinoid syndrome and advanced changes are associated with poor long-term survival. Active surgical and medical therapy of the tumour disease reduced the hormonal secretion and, combined with cardiological surveillance, made right ventricular heart failure a rare cause of death in these patients.

摘要

相似文献

1
Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome.
Br J Surg. 2001 Jun;88(6):865-72. doi: 10.1046/j.0007-1323.2001.01798.x.
2
Incidence and evolution of carcinoid syndrome in the heart.心脏类癌综合征的发病率及演变
J Heart Valve Dis. 1997 Nov;6(6):625-30.
3
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.类癌性心脏病。74例患者的临床及超声心动图表现谱
Circulation. 1993 Apr;87(4):1188-96. doi: 10.1161/01.cir.87.4.1188.
4
Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
Am J Cardiol. 1989 Feb 1;63(5):347-52. doi: 10.1016/0002-9149(89)90344-5.
5
Factors associated with progression of carcinoid heart disease.与类癌性心脏病进展相关的因素。
N Engl J Med. 2003 Mar 13;348(11):1005-15. doi: 10.1056/NEJMoa021451.
6
[Right ventricular failure as the presenting manifestation of a carcinoid syndrome].
Rev Med Interne. 2009 Jan;30(1):81-4. doi: 10.1016/j.revmed.2008.03.368. Epub 2008 May 12.
7
Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion.通过半肝切除术和原发性病变根治性切除术治疗类癌综合征。
Am J Surg. 1974 Jul;128(1):95-9. doi: 10.1016/0002-9610(74)90243-8.
8
[The tricuspid valve in carcinoid cardiopathy: characteristic echocardiographic aspects].
G Ital Cardiol. 1983 Nov;13(11):301-5.
9
[Carcinoid heart disease].[类癌性心脏病]
Arch Mal Coeur Vaiss. 1998 Jan;91(1):79-82.
10
Carcinoid pulmonary valvulopathy evaluated by real-time 3-dimensional transthoracic echocardiography.经实时三维经胸超声心动图评估的类癌性肺动脉瓣病变
J Am Soc Echocardiogr. 2008 Apr;21(4):407.e1-2. doi: 10.1016/j.echo.2007.08.015. Epub 2007 Oct 1.

引用本文的文献

1
Case report of carcinoid syndrome with multi-organ involvement.类癌综合征伴多器官受累的病例报告。
J Gastrointest Oncol. 2025 Aug 30;16(4):1756-1762. doi: 10.21037/jgo-2025-26. Epub 2025 Aug 8.
2
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors.重复5-羟吲哚乙酸测量作为类癌性心脏病预测指标的价值:一项针对小肠神经内分泌肿瘤患者的前瞻性5年随访研究。
Cancers (Basel). 2024 Nov 21;16(23):3896. doi: 10.3390/cancers16233896.
3
Prevalence, one-year-incidence and predictors of carcinoid heart disease.
类癌心脏病的患病率、一年发病率和预测因素。
Cardiovasc Ultrasound. 2023 Sep 26;21(1):18. doi: 10.1186/s12947-023-00316-6.
4
Carcinoid Heart Disease: A Case Report and Literature Review.类癌性心脏病:一例病例报告及文献综述
Arq Bras Cardiol. 2023 Jun;120(6):e20220245. doi: 10.36660/abc.20220245.
5
Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.类癌心脏病的管理:多学科协作。
Oncologist. 2023 Jul 5;28(7):575-583. doi: 10.1093/oncolo/oyad126.
6
Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease-A Retrospective Study.类癌性心脏病病程中小肠NET G1/G2神经内分泌肿瘤患者的分析——一项回顾性研究
J Clin Med. 2023 Jan 19;12(3):790. doi: 10.3390/jcm12030790.
7
Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study.一项大型验证研究表明,血清素和NT-proBNP水平升高可预测和检测类癌性心脏病。
Cancers (Basel). 2022 May 10;14(10):2361. doi: 10.3390/cancers14102361.
8
Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.小肠神经内分泌肿瘤患者的动脉功能、生物标志物、类癌综合征和类癌心脏病。
Endocrine. 2022 Jun;77(1):177-187. doi: 10.1007/s12020-022-03065-0. Epub 2022 May 10.
9
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).类癌性心脏病的超声心动图概要报告(ENETS类癌性心脏病工作组)
J Neuroendocrinol. 2022 Mar;34(3):e13060. doi: 10.1111/jne.13060. Epub 2021 Nov 26.
10
Brazilian Position Statement on the Use Of Multimodality Imaging in Cardio-Oncology - 2021.《巴西关于心脏肿瘤学中多模态成像应用的立场声明 - 2021》
Arq Bras Cardiol. 2021 Oct;117(4):845-909. doi: 10.36660/abc.20200266.